196 related articles for article (PubMed ID: 8027396)
1. Cytological screening and management of abnormalities in prevention of cervical cancer: an overview with stochastic modelling.
Sherlaw-Johnson C; Gallivan S; Jenkins D; Jones MH
J Clin Pathol; 1994 May; 47(5):430-5. PubMed ID: 8027396
[TBL] [Abstract][Full Text] [Related]
2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
3. Management of women with mild and moderate cervical dyskaryosis.
Flannelly G; Anderson D; Kitchener HC; Mann EM; Campbell M; Fisher P; Walker F; Templeton AA
BMJ; 1994 May; 308(6941):1399-403. PubMed ID: 8019248
[TBL] [Abstract][Full Text] [Related]
4. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
[TBL] [Abstract][Full Text] [Related]
5. A long-term study of women with normal colposcopy after referral with low-grade cytological abnormalities.
Smith MC; Keech SE; Perryman K; Soutter WP
BJOG; 2006 Nov; 113(11):1321-8. PubMed ID: 17059394
[TBL] [Abstract][Full Text] [Related]
6. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
TOMBOLA Group
BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
[TBL] [Abstract][Full Text] [Related]
7. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
8. Cervical screening: management of patients referred for colposcopy with smear abnormalities less severe than dyskaryosis.
Usman F; Hammond R
Cytopathology; 1998 Apr; 9(2):100-6. PubMed ID: 9577736
[TBL] [Abstract][Full Text] [Related]
9. Every woman with an abnormal cervical smear should be referred for treatment: debate.
Flannelly G; Kitchener H
Clin Obstet Gynecol; 1995 Sep; 38(3):585-91. PubMed ID: 8612368
[TBL] [Abstract][Full Text] [Related]
10. Outcome analysis of 4 years' follow-up of patients referred for colposcopy with one smear showing mild dyskaryosis.
Ahmed AS; Goumalatsos G; Akbar N; Lawton FG; Savvas M
Cytopathology; 2008 Apr; 19(2):94-105. PubMed ID: 17937774
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.
Kim JJ; Wright TC; Goldie SJ
JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059
[TBL] [Abstract][Full Text] [Related]
12. The value of colposcopy in screening cervical carcinoma.
Pete I; Tóth V; Bösze P
Eur J Gynaecol Oncol; 1998; 19(2):120-2. PubMed ID: 9611048
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the risks of cytologic surveillance of women with atypical cells or low-grade abnormalities on cervical smear: review of the literature.
Baldauf JJ; Ritter J
Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):193-9. PubMed ID: 9481574
[TBL] [Abstract][Full Text] [Related]
14. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
15. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.
Legood R; Gray A; Wolstenholme J; Moss S
BMJ; 2006 Jan; 332(7533):79-85. PubMed ID: 16399769
[TBL] [Abstract][Full Text] [Related]
16. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
17. Four and a half year follow up of women with dyskaryotic cervical smears.
Fletcher A; Metaxas N; Grubb C; Chamberlain J
BMJ; 1990 Sep; 301(6753):641-4. PubMed ID: 2224218
[TBL] [Abstract][Full Text] [Related]
18. Outcome of women with index smear showing mild dyskaryosis: effects of age and evidence of HPV infection.
Winn CM; Jones H
Cytopathology; 2005 Dec; 16(6):281-9. PubMed ID: 16303041
[TBL] [Abstract][Full Text] [Related]
19. Cytological and histological outcome following a borderline cervical smear.
Rawal N; Saridogan E; Weekes AW; Haq Khan N
J Obstet Gynaecol; 2003 Jul; 23(4):419-21. PubMed ID: 12881086
[TBL] [Abstract][Full Text] [Related]
20. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study.
Moss S; Gray A; Legood R; Vessey M; Patnick J; Kitchener H;
BMJ; 2006 Jan; 332(7533):83-5. PubMed ID: 16399706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
